John Castle
Chief Tech/Sci/R&D Officer at MONTE ROSA THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2024
Network origin in John Castle first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
21
| Public Company | Biotechnology | 21 |
| Public Company | Biotechnology | 18 | |
| Public Company | Biotechnology | 3 | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.
2
| Public Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Castle via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Consultant / Advisor | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree Doctorate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Doctorate Degree Masters Business Admin | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| The University of Reading | College/University | Undergraduate Degree Doctorate Degree | |
| Howard University | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
| Yale University | College/University | Graduate Degree Doctorate Degree | |
| University of British Columbia | College/University | Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The University of Colorado | College/University | Masters Business Admin | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| University of Utrecht | College/University | Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University Medical Center of Utrecht | College/University | Corporate Officer/Principal | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
JPT Peptide Technologies GmbH
 JPT Peptide Technologies GmbH Medical SpecialtiesHealth Technology JPT Peptide Technologies GmbH provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery. The firm’s products include custom peptides, modified & labeled peptides, clinical peptides, stable isotope-labeled peptides, SPOT peptides, immunogenic peptides, peptide libraries, peptide pools, peptide microarrays, peptide ELISA, enzyme profiling and epitope discovery service. The company was founded in 2004 and is headquartered in Berlin, Germany. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Georgetown University Law Center | College/University | Graduate Degree | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| NKARTA, INC. | Biotechnology | Chairman | |
| NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
Life Molecular Imaging Ltd.
 Life Molecular Imaging Ltd. Medical DistributorsDistribution Services Part of Old AMGL Interests 2 Ltd, Life Molecular Imaging Ltd. is a British company that wholesales diagnostic imaging solutions. The company is based in Warwick, UK. Life Molecular Imaging was founded in 2003. | Medical Distributors | Corporate Officer/Principal | |
Launchpad Therapeutics, Inc.
 Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Launchpad Therapeutics, Inc. develops novel therapeutics. | Miscellaneous Commercial Services | Director/Board Member President | |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
| MINK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Dren Bio, Inc.
 Dren Bio, Inc. BiotechnologyHealth Technology Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Columbia Technology Ventures
 Columbia Technology Ventures Investment ManagersFinance Columbia Technology Ventures (Columbia Ventures) is a venture capital subsidiary of The Trustees of Columbia University in The City of New York founded in 1982. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal |
Statistics
International
| United States | 35 |
| United Kingdom | 6 |
| Canada | 4 |
| Netherlands | 3 |
| Germany | 3 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 20 |
| Finance | 5 |
| Commercial Services | 4 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 177 |
| Corporate Officer/Principal | 85 |
| Independent Dir/Board Member | 56 |
| Chief Tech/Sci/R&D Officer | 30 |
| Director of Finance/CFO | 27 |
Most connected contacts
| Insiders | |
|---|---|
| Andrew Schiff | 35 |
| Ali Behbahani | 35 |
| Ulf Arne Wiinberg | 26 |
| Mohammed Malik | 24 |
| Chandra Paul Leo | 22 |
| Tom Dechaene | 19 |
| Alexander Mayweg | 18 |
| Shalini Sharp | 17 |
| Sean Marett | 15 |
| Christine Siu | 15 |
| Charles Ballantyne | 15 |
| Christian Cortis | 13 |
| Kimberly Blackwell | 13 |
| Anthony Manning | 12 |
| Markus Warmuth | 11 |
- Stock Market
- Insiders
- John Castle
- Company connections
